Mirum Pharmaceuticals, Inc. (MIRM) compared with its closest peers (TVTX, ORGO, NATR, INSM, OPK). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Travere Therapeutics, Organogenesis, Nature's Sunshine Products, Insmed, OPKO Health, TG Therapeutics, Axsome Therapeutics, Innoviva, Ardelyx and Ultragenyx Pharmaceutical share Mirum Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | $6.11B | -131.8 |
| Organogenesis Holdings Inc. (ORGO) | $231.61M | 34.5 |
| Nature's Sunshine Products, Inc. (NATR) | $252.32M | 13.2 |
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| OPKO Health, Inc. (OPK) | $1.10B | -4.2 |
| TG Therapeutics, Inc. (TGTX) | $8.31B | 18.7 |
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Innoviva, Inc. (INVA) | $1.52B | 4.0 |
| Ardelyx, Inc. (ARDX) | $968.09M | -22.4 |
| Ultragenyx Pharmaceutical Inc. (RARE) | $2.59B | -3.9 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
MIRM overview · MIRM earnings · MIRM financials · MIRM KPIs · MIRM documents · MIRM ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.